Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Save on this medicine
Same active ingredient — pay up to 50% less
These brands contain the same active ingredient (Diosmin + Hesperidin). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Daflon is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Dosage for Diosmin 450 mg and Hesperidin 50 mg: for acute hemorrhoidal attacks, take 3 tablets twice daily for the first 4 days, then 2 tablets twice daily for three days, and if required 1 tablet twice daily as a maintenance dosage. For chronic hemorrhoids, take 1 tablet twice daily. For chronic venous insufficiency, take 1 tablet twice daily initially for seven days; the duration may be increased depending on severity. Dosage for Diosmin 900 mg and Hesperidin 100 mg: for acute hemorrhoid, take 1 tablet thrice daily for the first 4 days, followed by 1 tablet twice daily for 3 days, and then 1 tablet once daily as a maintenance dose. For relapse of internal hemorrhoid and chronic hemorrhoid, take 1 tablet once daily for 3 months. For chronic venous insufficiency, take 1 tablet once daily for 2 to 6 months. For leg wounds, take 1 tablet once daily for 2 months.
Side Effects
A few cases of minor stomach upset and neurovegetative disturbances (a general feeling of discomfort) have been reported. These do not require stopping the treatment.
Cautions & Contraindications
Warnings & Precautions
If hemorrhoidal symptoms have not cleared within 15 days, the patient should seek medical advice. Diosmin (up to 900 mg/day) has been given to a small number of breast cancer patients with lymphedema following surgery and nodal irradiation; arm swelling was reduced, but there was no effect on the cancer itself. Animal studies and more than 20 years of clinical use in Europe have shown no evidence of carcinogenicity or mutagenicity when the components of Diosmin & Hesperidin are used as recommended. Nonetheless, as a precaution, Diosmin & Hesperidin is not recommended for patients with a history of cancer, since no specific studies have been carried out in this group.
Contraindications
Chronic venous insufficiency and its complications should be diagnosed by a physician, who should also monitor treatment. This product must not be used by anyone who is hypersensitive to any of its ingredients.